162 related articles for article (PubMed ID: 37628684)
1. Liver Involvement in Patients with Rare
Ronzoni L; Mureddu M; Malvestiti F; Moretti V; Bianco C; Periti G; Baldassarri M; Ariani F; Carrer A; Pelusi S; Renieri A; Prati D; Valenti L
Genes (Basel); 2023 Aug; 14(8):. PubMed ID: 37628684
[TBL] [Abstract][Full Text] [Related]
2. Identification of novel loss of function variants in MBOAT7 resulting in intellectual disability.
Heidari E; Caddeo A; Zarabadi K; Masoudi M; Tavasoli AR; Romeo S; Garshasbi M
Genomics; 2020 Nov; 112(6):4072-4077. PubMed ID: 32645526
[TBL] [Abstract][Full Text] [Related]
3. Mutations in MBOAT7, Encoding Lysophosphatidylinositol Acyltransferase I, Lead to Intellectual Disability Accompanied by Epilepsy and Autistic Features.
Johansen A; Rosti RO; Musaev D; Sticca E; Harripaul R; Zaki M; Çağlayan AO; Azam M; Sultan T; Froukh T; Reis A; Popp B; Ahmed I; John P; Ayub M; Ben-Omran T; Vincent JB; Gleeson JG; Abou Jamra R
Am J Hum Genet; 2016 Oct; 99(4):912-916. PubMed ID: 27616480
[TBL] [Abstract][Full Text] [Related]
4. LPIAT1/MBOAT7 contains a catalytic dyad transferring polyunsaturated fatty acids to lysophosphatidylinositol.
Caddeo A; Hedfalk K; Romeo S; Pingitore P
Biochim Biophys Acta Mol Cell Biol Lipids; 2021 May; 1866(5):158891. PubMed ID: 33513444
[TBL] [Abstract][Full Text] [Related]
5. The MBOAT7-TMC4 Variant rs641738 Increases Risk of Nonalcoholic Fatty Liver Disease in Individuals of European Descent.
Mancina RM; Dongiovanni P; Petta S; Pingitore P; Meroni M; Rametta R; Borén J; Montalcini T; Pujia A; Wiklund O; Hindy G; Spagnuolo R; Motta BM; Pipitone RM; Craxì A; Fargion S; Nobili V; Käkelä P; Kärjä V; Männistö V; Pihlajamäki J; Reilly DF; Castro-Perez J; Kozlitina J; Valenti L; Romeo S
Gastroenterology; 2016 May; 150(5):1219-1230.e6. PubMed ID: 26850495
[TBL] [Abstract][Full Text] [Related]
6. Genetic determinants of hepatic steatosis and serum cytokeratin-18 fragment levels in Taiwanese children.
Lin YC; Chang PF; Chang MH; Ni YH
Liver Int; 2018 Jul; 38(7):1300-1307. PubMed ID: 29314568
[TBL] [Abstract][Full Text] [Related]
7. The Membrane-bound O-Acyltransferase7 rs641738 Variant in Pediatric Nonalcoholic Fatty Liver Disease.
Di Sessa A; Umano GR; Cirillo G; Del Prete A; Iacomino R; Marzuillo P; Del Giudice EM
J Pediatr Gastroenterol Nutr; 2018 Jul; 67(1):69-74. PubMed ID: 29601441
[TBL] [Abstract][Full Text] [Related]
8. Association between MBOAT7 rs641738 polymorphism and non-alcoholic fatty liver in overweight or obese children.
Zusi C; Morandi A; Maguolo A; Corradi M; Costantini S; Mosca A; Crudele A; Mantovani A; Alisi A; Miraglia Del Giudice E; Targher G; Maffeis C
Nutr Metab Cardiovasc Dis; 2021 May; 31(5):1548-1555. PubMed ID: 33810963
[TBL] [Abstract][Full Text] [Related]
9. MBOAT7 in liver and extrahepatic diseases.
Caddeo A; Spagnuolo R; Maurotti S
Liver Int; 2023 Nov; 43(11):2351-2364. PubMed ID: 37605540
[TBL] [Abstract][Full Text] [Related]
10. Obesity-linked suppression of membrane-bound
Helsley RN; Varadharajan V; Brown AL; Gromovsky AD; Schugar RC; Ramachandiran I; Fung K; Kabbany MN; Banerjee R; Neumann CK; Finney C; Pathak P; Orabi D; Osborn LJ; Massey W; Zhang R; Kadam A; Sansbury BE; Pan C; Sacks J; Lee RG; Crooke RM; Graham MJ; Lemieux ME; Gogonea V; Kirwan JP; Allende DS; Civelek M; Fox PL; Rudel LL; Lusis AJ; Spite M; Brown JM
Elife; 2019 Oct; 8():. PubMed ID: 31621579
[TBL] [Abstract][Full Text] [Related]
11. The MBOAT7 rs641738 variant is associated with an improved outcome in primary sclerosing cholangitis.
Freund C; Wahlers A; Begli NH; Leopold Y; Klöters-Plachky P; Mehrabi A; Mohr I; Sander J; Rupp C; Gotthardt DN; Weiss KH
Clin Res Hepatol Gastroenterol; 2020 Oct; 44(5):646-652. PubMed ID: 31928970
[TBL] [Abstract][Full Text] [Related]
12. The membrane-bound O-acyltransferase domain-containing 7 variant rs641738 increases inflammation and fibrosis in chronic hepatitis B.
Thabet K; Chan HLY; Petta S; Mangia A; Berg T; Boonstra A; Brouwer WP; Abate ML; Wong VW; Nazmy M; Fischer J; Liddle C; George J; Eslam M
Hepatology; 2017 Jun; 65(6):1840-1850. PubMed ID: 28109005
[TBL] [Abstract][Full Text] [Related]
13. Mboat7 down-regulation by hyper-insulinemia induces fat accumulation in hepatocytes.
Meroni M; Dongiovanni P; Longo M; Carli F; Baselli G; Rametta R; Pelusi S; Badiali S; Maggioni M; Gaggini M; Fracanzani AL; Romeo S; Gatti S; Davidson NO; Gastaldelli A; Valenti L
EBioMedicine; 2020 Feb; 52():102658. PubMed ID: 32058943
[TBL] [Abstract][Full Text] [Related]
14. Expanding the phenotype of phospholipid remodelling disease due to MBOAT7 gene defect.
Yalnızoǧlu D; Özgül RK; Oǧuz KK; Özer B; Yücel-Yılmaz D; Gürbüz B; Serdaroǧlu E; Erol İ; Topçu M; Dursun A
J Inherit Metab Dis; 2019 Mar; 42(2):381-388. PubMed ID: 30701556
[TBL] [Abstract][Full Text] [Related]
15. Expanding the phenotypic spectrum of MBOAT7-related intellectual disability.
Jacher JE; Roy N; Ghaziuddin M; Innis JW
Am J Med Genet B Neuropsychiatr Genet; 2019 Oct; 180(7):483-487. PubMed ID: 31282596
[TBL] [Abstract][Full Text] [Related]
16. Membrane-bound
Varadharajan V; Ramachandiran I; Massey WJ; Jain R; Banerjee R; Horak AJ; McMullen MR; Huang E; Bellar A; Lorkowski SW; Gulshan K; Helsley RN; James I; Pathak V; Dasarathy J; Welch N; Dasarathy S; Streem D; Reizes O; Allende DS; Smith JD; Simcox J; Nagy LE; Brown JM
Elife; 2024 Apr; 12():. PubMed ID: 38648183
[TBL] [Abstract][Full Text] [Related]
17. LPIAT1/MBOAT7 depletion increases triglyceride synthesis fueled by high phosphatidylinositol turnover.
Tanaka Y; Shimanaka Y; Caddeo A; Kubo T; Mao Y; Kubota T; Kubota N; Yamauchi T; Mancina RM; Baselli G; Luukkonen P; Pihlajamäki J; Yki-Järvinen H; Valenti L; Arai H; Romeo S; Kono N
Gut; 2021 Jan; 70(1):180-193. PubMed ID: 32253259
[TBL] [Abstract][Full Text] [Related]
18. Loss of hepatic Mboat7 leads to liver fibrosis.
Thangapandi VR; Knittelfelder O; Brosch M; Patsenker E; Vvedenskaya O; Buch S; Hinz S; Hendricks A; Nati M; Herrmann A; Rekhade DR; Berg T; Matz-Soja M; Huse K; Klipp E; Pauling JK; Wodke JA; Miranda Ackerman J; Bonin MV; Aigner E; Datz C; von Schönfels W; Nehring S; Zeissig S; Röcken C; Dahl A; Chavakis T; Stickel F; Shevchenko A; Schafmayer C; Hampe J; Subramanian P
Gut; 2021 May; 70(5):940-950. PubMed ID: 32591434
[TBL] [Abstract][Full Text] [Related]
19. Hepatic deletion of Mboat7 (LPIAT1) causes activation of SREBP-1c and fatty liver.
Xia M; Chandrasekaran P; Rong S; Fu X; Mitsche MA
J Lipid Res; 2021; 62():100031. PubMed ID: 32859645
[TBL] [Abstract][Full Text] [Related]
20. MBOAT7 rs641738 variant and hepatocellular carcinoma in non-cirrhotic individuals.
Donati B; Dongiovanni P; Romeo S; Meroni M; McCain M; Miele L; Petta S; Maier S; Rosso C; De Luca L; Vanni E; Grimaudo S; Romagnoli R; Colli F; Ferri F; Mancina RM; Iruzubieta P; Craxi A; Fracanzani AL; Grieco A; Corradini SG; Aghemo A; Colombo M; Soardo G; Bugianesi E; Reeves H; Anstee QM; Fargion S; Valenti L
Sci Rep; 2017 Jul; 7(1):4492. PubMed ID: 28674415
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
